USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND TO MUC16 AND CD3 IN COMBINATION WITH 4-1BB CO-STIMULATION

MA56537AUndetermined Publication Date: 2022-04-27REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA56537
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-06-21
Filing Date
2020-06-19
Publication Date
2022-04-27
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.